Built on a history of healthcare investing
Investment Manager
Growth opportunity
Healthcare costs are increasing, meaning a shift towards value-based approaches is likely needed, with lower costs and improved patient outcomes. This enables opportunities for healthcare companies best positioned to facilitate the transition towards value over quantity.
Disruptive themes
Healthcare is home to disruptive themes such as targeted oncology, liquid biopsy, gene therapy, orphan diseases, as well as others that represent compelling long-term growth opportunities.
Innovative sector
The healthcare sector is dynamic, and regularly sees new innovations and the introduction of groundbreaking technologies.
Dynamic approach
The healthcare sector can be sensitive to market movements. Employing an active, specialised approach may enable the active Healthcare ETF to capture long-term growth opportunities, as well as navigate through shorter-term periods of volatility and dislocation.
Experienced active management
Westfield are experienced active managers, using a bottom-up process to identify companies that meet their strict fundamental criteria and performing a qualitative review on each identified company.
William A. Muggia | President, CEO & CIO
Mr. Muggia is President, Chief Executive Officer and Chief Investment Officer at Westfield Capital Management, and he also chairs the Investment Committee and serves as Market Strategist. He joined Westfield in 1994. Previously, he spent three years at Alex. Brown & Sons, and eight years at Kidder Peabody & Co. He received a BA from Middlebury and an MBA from Harvard Business School.
Matthew R. Renna | Partner and Portfolio Manager
Mr. Renna joined Westfield in 2013 as a member of the Investment Committee covering the Healthcare sector. Prior to joining Westfield, he was with Vinik Asset Management as a Healthcare Portfolio Manager. His professional experience also includes Director, SMID Growth Equity team at BlackRock, inc., Senior Equity Analyst at RA Capital Management and Director, Healthcare/Biotechnology at Soleil Securities Corporation, Neponset Equity Research. Matthew began his career in the Healthcare industry at Merck & Co., before entering equity research as a Senior Research Associate covering Specialty Pharmaceuticals at Leerink Swann LLC. Mr. Renna began his investment career in 2004.
The Healthcare ETF is actively managed by the expert team at Westfield Capital Management.
Westfield Capital uses a bottom-up process to identify companies that meet their strict fundamental criteria and then performs a qualitative review on each identified company to select approximately 30 to 50 companies for inclusion in the active Healthcare ETF’s portfolio. The Subadvisor’s research may include personal interviews and other contact with company management.
In constructing the ETF’s portfolio, the investment team seeks to identify companies that it believes possess the following characteristics:
Westfield favours investing in earnings growth stocks given our conviction that stock prices follow earnings progress and that they offer the best opportunity for superior real rates of return.
Westfield believes that reasonably priced stocks of companies with high foreseen earnings potential are best identified through in-depth, fundamental research. The Investment Committee’s experience, extensive research, and first-hand knowledge of company operations derived through on-site visits and meetings with management provide our competitive edge. They utilize a team approach within a disciplined investment process that enables their analysts to impact portfolios. Constant analysis and measurement of their investment process ensures that they are continually improving their approach to asset management.
Harbor Health Care UCITS ETF (WELL) aims to provide exposure to the secular growth and innovation of the U.S. healthcare system, while achieving alpha relative to the broader healthcare sector by investing in quality businesses with differentiated products, technologies, and services which meet the team’s disciplined valuation criteria.
This includes disruptive themes such as targeted oncology, liquid biopsy, gene therapy, orphan diseases, and others that represent compelling long-term growth opportunities.
*This fund changed strategy on 12/09/2024
Key Risks
Past performance is not indicative of future performance. When you invest in ETFs your capital is fully at risk and may not get back the amount originally invested. Exchange rates can have a positive or negative effect on returns. The value of equities and equity-related securities can be affected by daily stock and currency market movements.
Source: HANetf, data as of 31.08.2026. Please note that all performance figures are showing net data. Performance before inception is based on back-tested data. Back-testing is the process of evaluating an investment strategy by applying it to historical data to simulate what the performance of such a strategy would have been. Back-tested data does not represent actual performance and should not be interpreted as an indication of actual or future performance. Past performance for the index is in USD. Past performance is not an indicator for future results and should not be the sole factor of consideration when selecting a product. Investors should read the prospectus of the Issuer (Prospectus) before investing and should refer to the section of the Prospectus entitled Risk Factors for further details of risks associated with an investment in this product. If fund is less than 12 months old, YTD field will be calculated since inception. When you invest in ETFs your capital is at risk.
No. of holdings: 46
The healthcare sector is complex and fast-evolving, with constant innovation, shifting regulations, and breakthroughs in biotech, pharmaceuticals, and medical technology. An active approach allows portfolio managers to carefully research and select companies that are best positioned for growth, while avoiding those facing risks or setbacks. Active management also helps navigate sudden changes—like drug approvals or policy changes—that can have a big impact on stock performance.
An active ETF is designed to do more than just follow the market—it aims to beat it. Professional managers actively choose investments they believe will perform well, rather than just copying a list of stocks in an index. This gives them the flexibility to look for better opportunities and manage risks more carefully, all while staying true to the fund’s goals and values.
ETFs offer the benefits of flexibility, lower costs, and greater transparency. They can be traded throughout the day like a stock, often with lower management fees than mutual funds. For healthcare investors, this means quicker access to opportunities, more control, and real-time visibility into what the fund holds—all without sacrificing professional management.
Read our extensive list of FAQs on active management by clicking the button below.
Wellness and longevity equity exposure refers to investments in companies linked to improving health outcomes, extending healthy lifespan, and supporting preventative healthcare and wellbeing. This can include healthcare services, medical technology, diagnostics, digital health platforms, nutrition, fitness, and consumer wellness businesses. The theme is typically driven by structural shifts such as ageing populations, rising healthcare spending, and increased focus on preventive rather than reactive care. The theme is typically driven by structural shifts such as ageing populations, rising healthcare spending, and increased focus on preventive rather than reactive care. This represents a meaningful shift in how healthcare value is created — from treating illness after it occurs toward managing health proactively over a person’s lifetime — which is reshaping where capital flows within the sector.
Wellness-focused strategies can include companies across several sub-sectors such as healthcare providers, medical devices, diagnostics, pharmaceuticals with preventative applications, digital health platforms, fitness and lifestyle companies, and nutrition or functional food businesses. Some methodologies also include companies involved in health data analytics and personalised medicine. The breadth of the theme means exposure can extend beyond traditional healthcare into consumer and technology sectors, depending on how “wellness” is defined within the investment framework.
Long-term drivers include ageing populations, rising prevalence of chronic diseases, increasing healthcare expenditure, and greater consumer focus on preventative health. Advances in medical technology, biotechnology, and data-driven healthcare are also expanding the tools available for early diagnosis and personalised treatment. In addition, post-pandemic awareness of health resilience has reinforced demand for wellness-oriented products and services. These structural trends tend to evolve gradually over time, making the theme more long-duration in nature rather than cyclical.
Preventative healthcare focuses on reducing the risk of disease through early detection, lifestyle intervention, and ongoing monitoring, whereas traditional healthcare is more reactive and centred on treating illness after it occurs. This shift is enabled by advances in diagnostics, wearable technology, and data analytics, which allow earlier identification of health risks. Preventative models aim to reduce long-term healthcare costs and improve quality of life outcomes. From an investment perspective, this transition can create growth opportunities across diagnostics, digital health, and wellness services.
Ageing populations increase demand for healthcare services, chronic disease management, and age-related medical technologies. As life expectancy rises in many developed and emerging markets, healthcare systems are shifting focus toward maintaining quality of life for longer periods. This can drive demand for pharmaceuticals, medical devices, diagnostics, and home healthcare services. At the same time, older populations often have higher per-capita healthcare spending, which can support long-term structural growth in the sector.
Consumer behaviour plays a significant role in the wellness sector as individuals increasingly prioritise fitness, nutrition, mental health, and preventative care. This has contributed to growth in areas such as wearable health devices, personalised nutrition, subscription-based wellness services, and fitness technology platforms. Social trends, digital engagement, and increased access to health information have accelerated this shift. As a result, wellness exposure often spans both healthcare and consumer discretionary sectors, depending on the investment methodology.
Key risks include regulatory change, healthcare reimbursement pressures, technological disruption, and valuation sensitivity in high-growth subsectors. Many companies in the wellness and longevity space operate in regulated environments, meaning policy changes can affect pricing, approval pathways, or reimbursement structures. In addition, innovation cycles can be unpredictable, and not all technologies achieve commercial success. Broader market risks such as interest rate changes and equity market volatility can also affect valuations, particularly for growth-oriented companies.
Digital health plays an increasingly important role in the wellness theme by enabling remote monitoring, data-driven diagnostics, and personalised care delivery. This includes telemedicine platforms, health tracking applications, wearable devices, and AI-driven diagnostic tools. These technologies aim to make healthcare more accessible, efficient, and preventative. As healthcare systems adopt more digital infrastructure, companies operating in this space are positioned to benefit as care increasingly shifts outside traditional hospital settings — though regulatory approval, data privacy requirements, and reimbursement policy will continue to shape which technologies achieve widespread adoption.
Relevant healthcare innovation stocks may include biotechnology, pharmaceuticals, diagnostics, medical devices and surgical technology companies. Examples include Ascendis Pharma, Rhythm Pharmaceuticals, Eli Lilly, Legend Biotech, Gilead Sciences, Natera, Insmed, Revolution Medicines, AbbVie and Intuitive Surgical. These companies reflect themes such as targeted therapies, obesity and metabolic disease, oncology, rare diseases, liquid biopsy, respiratory disease, immunology and robotic surgery. Investors researching this space should consider clinical trial results, regulatory approvals, patent life, pricing pressure, reimbursement, product concentration and valuation. Healthcare innovation can offer differentiated growth drivers, but individual stocks may be highly sensitive to drug data, approval decisions and changes in policy or competitive pipelines.
Disclaimer: These FAQs have been generated with the assistance of AI and may contain errors or omissions. They are provided for general information only and do not constitute investment advice, a recommendation, or an invitation to buy or sell any investment.
Explore our expert-written monthly fund reports, periodic reviews, and key insights.
Three drivers of the health care sector in 2025
August 2025
ETFs are getting active – is your portfolio ready?
May 2025
ETFs Are Gaining Ground Over Mutual Funds
February 2025
Health care’s Comeback: Why 2025 Could Revive the Sector’s Vital Signs
December 2024
Why would you use an ETF over a mutual fund?
October 2024
HANetf’s 2024 Outlook
December 2023
Healthcare ETF Quarterly Report | July 2026
July 2026
Health Care ETF Quarterly Report | April 2026
April 2026
Health Care ETF Quarterly Report | October 2025
October 2025
Health Care ETF Quarterly Report | July 2025
July 2025
Health Care ETF Quarterly Report | April 2025
April 2025
Health Care ETF Quarterly Report | January 2025
January 2025
Health Care ETF Quarterly Report | October 2024
2024 – The year active ETFs took off
The rise of active ETFs: How they’re gaining popularity and why it matters
About Investment Manager
Westfield Capital Management is dedicated to providing strong and consistent investment performance based on a disciplined, team-based approach, with exceptional client service. Westfield believes their greatest strength comes from the collective wisdom of a fully engaged and inspired team working together with clear objectives. Additionally, Westfield embraces their employee ownership structure, which aligns the advancement of the organisation with their clients, and serves to attract and retain exceptional talent.
Select Your Country
Select Your Investor Type
Choose a brokerage
IG
AJ Bell
Invest Engine
Hargreaves Lansdown
Halifax
Interactive Investor
Charles Stanley
Trading 212
You are now leaving HANetf's website and accessing a third-party website. HANetf may provide access to information, products, or services offered on websites that are owned or operated by other companies ("third-party websites"). We provide this access through the use of hyperlinks that automatically move you from a HANetf website to the third-party site.
While we do our best to provide you with helpful, trustworthy resources, HANetf cannot endorse, approve, or guarantee information, products, services, or recommendations provided at a third-party website. Since we may not always know when information on a linked site changes, HANetf is not responsible for the content or accuracy of any third-party website. HANetf shall not be responsible for any loss or damage of any sort resulting from the use of a link on its websites nor will it be liable for any failure of products or services advertised or provided on these linked sites.
HANetf offers you links on an "as is" basis. When you visit a third-party website by using a link on a HANetf site, you will no longer be protected by the HANetf privacy policy or security practices. The data collection, use, and protection practices of the linked site may differ from the practices of HANetf sites. You should familiarize yourself with the privacy policy and security practices of the linked website. Those are the policies and practices that will apply to your use of the linked website, not the HANetf policies and practices.
Here are some tips to help you tell if you have left a HANetf website:
Important Notice: HANetf is a provider of Exchange Traded Funds (ETFs) and Exchange Traded Commodities (ETCs). We do not sell investment products directly to individual investors. Our funds are available through regulated investment platforms and brokers. Our only official website is www.hanetf.com. Any other domain is not affiliated with or authorised by HANetf in any way. If you suspect fraudulent activity, please contact your local financial regulator and/or the police and report the website or individual involved.